7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The Leu72Met Polymorphism of the Prepro-ghrelin Gene is Associated With Alcohol Consumption and Subjective Responses to Alcohol: Preliminary Findings

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          The orexigenic peptide ghrelin may enhance the incentive value of food-, drug- and alcohol-related rewards. Consistent with preclinical findings, human studies indicate a role of ghrelin in alcohol use disorders (AUD). In the present study an a priori hypothesis-driven analysis was conducted to investigate whether a Leu72Met missense polymorphism (rs696217) in the prepro-ghrelin gene ( GHRL), is associated with AUD, alcohol consumption and subjective responses to alcohol.

          Method

          Association analysis was performed using the National Institute on Alcohol Abuse and Alcoholism (NIAAA) clinical sample, comprising AUD individuals and controls ( N = 1127). Then, a post-hoc analysis using data from a human laboratory study of intravenous alcohol self-administration (IV-ASA, N = 144) was performed to investigate the association of this SNP with subjective responses following a fixed dose of alcohol (priming phase) and alcohol self-administration ( ad libitum phase).

          Results

          The case-control study revealed a trend association ( N = 1127, OR = 0.665, CI = 0.44–1.01, P = 0.056) between AUD diagnosis and Leu72Met. In AUD subjects, the SNP was associated with significantly lower average drinks per day ( n = 567, β = −2.49, 95% CI = −4.34 to −0.64, P = 0.008) and significantly fewer heavy drinking days ( n = 567, β = −12.00, 95% CI = −19.10 to −4.89, P < 0.001). The IV-ASA study further revealed that 72Met carriers had greater subjective responses to alcohol ( P < 0.05) when compared to Leu72Leu both at priming and during ad lib self-administration.

          Conclusion

          Although preliminary, these findings suggest that the Leu72Leu genotype may lead to increased risk of AUD possibly via mechanisms involving a lower response to alcohol resulting in excessive alcohol consumption. Further investigations are warranted.

          Short Summary

          We investigated whether a Leu72Met missense polymorphism in the prepro-ghrelin gene, is associated with alcohol use disorder, alcohol consumption and subjective responses to alcohol. Although preliminary, results suggest that the Leu72Leu genotype may lead to increased risk of alcohol use disorder possibly via mechanisms involving a lower response to alcohol.

          Related collections

          Author and article information

          Journal
          Alcohol Alcohol
          Alcohol Alcohol
          alcalc
          Alcohol and Alcoholism (Oxford, Oxfordshire)
          Oxford University Press
          0735-0414
          1464-3502
          July 2017
          08 May 2017
          08 May 2017
          : 52
          : 4
          : 425-430
          Affiliations
          [1 ] Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism (NIAAA) and National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), 10 Center Drive (10CRC/15330), Bethesda, MD 20892, USA
          [2 ] Department of Pharmacology, The Sahlgrenska Academy at University of Gothenburg , Box 431, 405 30 Gothenburg, Sweden
          [3 ] Section on Human Psychopharmacology, NIAAA, NIH, 10 Center Drive (10CRC/15330), Bethesda, MD 20892, USA
          [4 ] Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University , 1101 E Marshall Street, Box 980033, Richmond, VA 23298, USA
          [5 ] Office of the Clinical Director, NIAAA, NIH, 10 Center Drive (10CRC/15330), Bethesda, MD 20892, USA
          [6 ] Laboratory of Neurogenetics, NIAAA, NIH, 5625 Fishers Lane, Rockville, MD 20892, USA
          [7 ] Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University , 121 South Main Street, Providence, RI 02912, USA
          Author notes
          [* ]Corresponding author: Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, NIAAA & NIDA, NIH, 10 Center Drive (10CRC/15330) MSC 1108, Room 1-5429, Bethesda, MD 20892-1108, USA. Tel.: +1-301-435-9398; Fax: +1-301-402-0445; E-mail: lorenzo.leggio@ 123456nih.gov
          Article
          PMC5860519 PMC5860519 5860519 agx021
          10.1093/alcalc/agx021
          5860519
          28481975
          94e93de7-0197-413c-b778-e75158aa62a4
          Medical Council on Alcohol and Oxford University Press 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
          History
          : 28 October 2016
          : 22 February 2017
          : 29 March 2017
          Page count
          Pages: 6
          Funding
          Funded by: National Institutes of Health 10.13039/100000002
          Funded by: NIH Clinical Center 10.13039/100000098
          Funded by: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
          Funded by: Division of Intramural Clinical and Biological Research
          Funded by: National Institute on Drug Abuse Intramural Research Program
          Funded by: Computerized Alcohol Infusion System (CAIS)
          Funded by: NIAAA-funded Indiana Alcohol Research Center
          Award ID: AA007611
          Funded by: Swedish Brain Foundation 10.13039/501100003792
          Funded by: Swedish Society for Medical Research 10.13039/501100003748
          Award ID: 148251
          Funded by: Sahlgrenska University Hospital 10.13039/501100005754
          Categories
          Article

          Comments

          Comment on this article